Abstract
Objective: Blood conservation has become one of the most important issues in cardiac surgery. We clarified preoperative predictors of the need for blood transfusions during coronary aretery bypass graft surgery.Methods: Subjects were 89 patients—66 men (74%) and 23 women (26%) 40 to 84 years old (mean: 66.2±8.3 years)—undergoing isolated coronary artery bypass surgery from September 1997 to December 1999. Of these, 66 patients (74%) received transfusion during hospitalization and 23 (26%) did not. Nine risk factors detected by univariate study were entered in a multivariate logistic regression model of the relationship between preoperative variables and blood transfusion.Results: Independent predictors were emergency surgery (P=.0023), lower hematocrit (P=.0027), older age (P=.0043), and the presence of peripheral vascular disease (P=.0070). Optimal cutoff of hematocrit for blood transfusion was 39% and age 64 years via receiver-operating characteristics curves based on the relation between sensitivity and specificity.Conclusion: Patients older than 64 years with hematocrit less than 39% and/or peripheral vascular disease should be treated routinely using preoperative storage of autologous blood whenever the patient’s condition permits. For patients undergoing emergency surgery, further studies are required, including lowering transfusion threshold and using determinants other than hematocrit.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yasui H, Osada H, Ide H, Fujimura S. Thoracic and cardiovascular surgery in Japan during 1997: annual report by the Japanese association for thoracic surgery. Jpn J Tharac Cardiovasc Surg, 1999; 47: 237–51.
Loop FD, Lytle BW, Cosgrove DM, Goormastic M, Taylor PC, Golding LA, et al. Coronary artery bypass surgery in the elderly: indications and outcome. Cleve Clin J Med 1988; 55: 23–34.
Goodnough LT, Johnston MF, Toy PT. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991; 265: 86–90.
Scott WJ, Rode R, Castlemain B, Kessler R, Follis F, Pett SB, et al. Efficacy, complications, and cost of a comprehensive blood conservation pregram for cardiac operations. J Thorac Cardiovasc Surg 1992; 103: 1001–7.
Kytola L, Nuutinen L, Myllyla G. Transfusion policies in coronary artery bypass: a nationwide survey in Finland. Acta Anaesthesiol Scand 1998; 42: 178–83.
Swets JA, Pickett RM, Whitehead SF, Getty DJ, Schnur JA, Swets JB, et al. Assessment of diagnostic technologies. Science 1979; 205: 753–9.
De Caterina R, Giannessi D, Crea F, Chierchia S, Bernini W, Gazzetti P, et al. Inhibition of platelet function by injectable isosorbide dinitrate. Am J Cardiol 1984; 53: 1683–7.
Diodati J, Theroux P, Latour JG, Lacoste L, Lam JY, Waters D. Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocaridial infarction. Am J Cardiol 1990; 66: 683–8.
Magovern JA, Sakert T, Benckart DH, Burkholder JA, Liebler GA, Magovern GJ, et al. A model for predicting transfusion after coronary artery bypass grafting. Ann Thorac Surg 1996; 61: 27–32.
Cosgrove DM, Loop FD, Lytle BW, Gill CC, Golding LR, Taylor PC, et al. Determinants of blood utilization during myocardial revascularization. Ann Thorac Surg 1985; 40: 380–4.
Ferraris VA, Gildengorin V. Predictors of excessive blood use after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1989; 98: 492–7.
Bilfinger TV, Conti VR. Blood conservation in coronary artery bypass surgery: prediction with assistance of a computer model. Thorac Cardiovasc Surg 1989; 37: 365–8.
Utley JR, Wallace DJ, Thomason ME, Mutch DW, Staton L, Brown V, et al. Correlates of preoperative hematocrit value in patients undergoing coronary artery bypass. J Thorac Cardiovasc Surg 1989; 98: 451–3.
Kulier A, Gombotz H, Stubenvoll E. Erythropoietin in patients undergoing coronary artery bypass graft surgery. Clin Investig 1994; 72 (Suppl 6): S19–24.
Gombotz H. Subcutaneous epoetin alpha as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery. Semin Hematol 1997; 33 (Suppl 2): 69–72.
Levy JH, Pifarre R, Schaff HV, Horrow JC, Albus R, Spiess B, et al. A multicenter, double-blind, placebocontrolled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 1995; 92: 2236–44.
Jones JW, Rawitscher RE, McLean TR, Beal AC Jr, Thornby JI. Benefit from combining blood conservation measures in cardiac operations. Ann Thorac Surg 1991; 51: 541–6.
Goodnough LT, Despotis GJ, Hogue CW Jr, Ferguson TB Jr. On the need for improved transfusion indicators in cardiac surgery. Ann Thorac Surg 1995; 60: 473–80.
Paone G, Silverman NA. The paradox of on-bypass transfusion threshold in blood conservation. Circulation 1997; 96 (Suppl II):.
Mossad E, Estafanous F. Con: A hematocrit of 20% is not adequate for separation from cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1996; 10: 294–5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Isomatsu, Y., Tsukui, H., Hoshino, S. et al. Predicting blood transfusion factors in coronary artery bypass surgery. Jpn J Thorac Caridovasc Surg 49, 438–442 (2001). https://doi.org/10.1007/BF02913909
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02913909